EPF is developing a novel cardiac ablation catheter for pulmonary vein isolation and atrial fibrillation treatment. The technology under clinical investigation is a unique single shot ablation catheter with anchoring and stabilization features, that aims to improve both the effectiveness of the clinical outcome and the ease of use for the EP.
Location: Italy, Lombardy, Milan
Investors 2
| Date | Name | Website |
| - | TechWald H... | techwald.c... |
| - | Indaco Ven... | indacosgr.... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 09.07.2023 | Illuminating Italy’s Medical Device Innovators: Unveiling 15... | Table of Contents show 1 MgShell: Advancing Treatment for Macular Degeneration 2 Wita: Empowering ... | eustartup.... |
| 02.08.2021 | ElectroPhysiology Frontiers announces appointment of Avi Fis... | MILAN, Aug. 2, 2021 /PRNewswire/ -- ElectroPhysiology Frontiers S.p.A. (EPF), announced that its B... | prnewswire... |
| 02.08.2021 | ElectroPhysiology Frontiers announces appointment of Avi Fis... | MILAN, Aug. 2, 2021 /PRNewswire/ -- ElectroPhysiology Frontiers S.p.A. (EPF), announced that its Boa... | marketscre... |
| 02.08.2021 | ElectroPhysiology Frontiers announces appointment of Avi Fis... | MILAN, Aug. 2, 2021 /PRNewswire/ -- ElectroPhysiology Frontiers S.p.A. (EPF), announced that its Boa... | en.prnasia... |